Related Articles
EVI‑1 acts as an oncogene and positively regulates calreticulin in breast cancer Retraction in /10.3892/mmr.2023.13112
Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancer
The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review)
Prognostic analysis of triple-negative breast cancer patients treated with adjuvant chemotherapy of fluorouracil, epirubicin and cyclophosphamide
Clinical characteristics and prognostic analysis of triple‑negative breast cancer patients